A Phase I Clinical Study of a Single Subcutaneous Injection of HRS-5632 in Healthy Subjects

NCT06732154 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: HRS-5632
DRUG: Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.